| Comparison of cardiac influences of antipsychotic drugs in patients with schizophrenia | Erhan KURT, Bilbaşar AKMAN, Gazi ALATAŞ, Timuçin ORAL, Sinan DAĞDELEN | 155–161 |
| Change in the preference of the psychotropic drugs and consultation liaison psychiatry practice | Elif ONUR, Selma POLAT, Yalçın Neslihan GÜRZ, Beyazıt YEMEZ, Can CİMİLLİ | 167–173 |
| Psychiatric comorbidities in schizophrenic outpatients | İsmail AK, Ahmet TİRYAKİ, Evrim ÖZKORUMAK | 174–180 |
| Comparison of the schizotypal features of unaffected first degree relatives of schizophrenic patients with that of healthy control subjects: A preliminary study | Şenol TURAN, Murat EMÜL, Mihriban DALKIRAN, Ruhi YAVUZ, Alaattin DURAN, Müfit UĞUR | 181–185 |
| Assessment of psychiatric diagnosis, alexithymia, temperament and character of patients with irritable bowel syndrome | İbrahim TAYMUR, Sefa GÜLİTER, Nurper ERBERK-ÖZEN, Cumhur BORATAV | 186–194 |
| Methylphenidate induced hallucinations: Case report | Osman ABALI, Nahit Motavallı MUKADDES | 195–197 |
| A case of angioedema due to risperidone | İhsan Tuncer OKAY, Dankı Demet ERKEN, Özcan KILIÇO, Nesrin DİLBAZ | 198–202 |
| Quetiapine augmentation in treatment of panic disorder: A case report | Elif ONUR | 203–206 |
| Schizophrenia and diabetes mellitus: Diabetes mellitus or metabolic syndrome caused by new generation antipsychotics | Sunar BİRSÖZ, Özmen METİN, Evrim USTA | 207–216 |
| Serotonin sendromuna güncel bir yaklaşım | Neşe KOCABAŞOĞLU, Samuray ÖZDEMİR | 217–225 |